Financial summary: Consolidated statement of income

Consolidated statement of income

In € millions, for the year ended December 31

2013

2014

2015

20163,4

2017

2018

20195

2020

2021

2022

Revenue

14,590

14,296

14,859

9,434

9,612

9,256

9,276

8,530

9,587

10,846

Operating income

958

987

1,573

923

825

605

841

963

1,118

708

Adjusted operating income1

897

1,072

1,462

928

905

798

991

1,099

1,092

789

Financing income and expenses

(200)

(156)

(114)

(91)

(78)

(52)

(76)

(69)

(39)

(124)

Income tax

(111)

(252)

(416)

(234)

(253)

(118)

(230)

(241)

(246)

(214)

Results from associates and joint ventures

14

21

17

18

17

20

20

25

26

18

Profit/(loss) for the period from continuing operations

661

600

1,060

616

511

455

555

678

859

388

Discontinued operations

131

18

6

436

393

6,274

22

(7)

6

(10)

Non-controlling interests

(68)

(72)

(87)

(82)

(72)

(55)

(38)

(41)

(36)

(26)

Net income, attributable to shareholders

724

546

979

970

832

6,674

539

630

829

352

Common shares, in millions at year-end

242.6

246.0

249.0

252.2

252.6

256.2

199.6

190.6

181.6

174.4

Dividend2

210

212

222

239

1,287

390

1,423

366

365

347

Number of employees at year-end

49,600

47,200

45,600

36,300

35,700

34,500

33,800

32,200

32,800

35,200

Average number of employees

50,200

48,200

46,100

36,200

36,200

34,900

34,200

33,000

32,700

35,100

Employee benefits

2,950

2,824

2,728

1,794

1,935

1,976

1,875

1,850

1,773

1,960

Average revenue per employee (in €1,000)

291

297

322

261

266

265

271

258

293

309

Average operating income per employee (in €1,000)

19

20

34

25

23

17

25

29

34

20

 

 

 

 

 

 

 

 

 

 

 

Ratios

 

 

 

 

 

 

 

 

 

 

ROS%1

6.1

7.5

9.8

9.8

9.4

8.6

10.7

12.9

11.4

7.3

OPI margin%1

6.6

6.9

10.6

9.8

8.6

6.5

9.1

11.3

11.7

6.5

ROI%1

9.0

10.9

14.0

14.4

13.9

12.6

14.1

16.1

16.0

9.8

Net income in % of shareholders’ equity

12.9

9.5

15.1

14.8

14.2

56.4

8.5

11.0

15.3

8.1

Employee benefits in % of revenue

20.2

19.8

18.4

19.0

20.1

21.3

20.2

21.7

18.5

18.1

Interest coverage (operating income / net interest on net debt)

5.1

8.6

16.2

13.2

12.3

8.0

14.3

18.5

18.0

8.1

 

 

 

 

 

 

 

 

 

 

 

Per share information

 

 

 

 

 

 

 

 

 

 

Net income

3.00

2.23

3.95

3.87

3.31

26.19

2.53

3.29

4.48

2.01

Adjusted earnings per share

2.62

2.81

4.02

3.80

4.40

1.91

3.10

3.88

4.07

2.45

Shareholders’ equity

23.06

23.53

26.04

25.99

23.22

46.19

32.33

30.26

30.32

25.43

Highest share price during the year

56.08

60.77

74.81

64.74

82.64

82.70

91.86

91.60

107.80

98.50

Lowest share price during the year

42.65

47.63

55.65

50.17

59.11

68.82

69.12

48.50

83.50

56.22

Year-end share price

55.71

57.65

61.68

59.39

73.02

70.40

90.69

87.86

96.50

62.56

1

Refer to the glossary for definitions.

2

Cash dividend paid to shareholders of AkzoNobel.

3

Represented to present the Specialty Chemicals business as discontinued operations.

4

Represented to the new adjusted earnings per share definition, which no longer excludes post-tax amortization charges.

5

Includes the impact of the adoption of IFRS 16 “Leases”.